Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor in humans, accounting for 52% of all brain tumor cases.
1, 2 The median survival is
. Optimal therapy consists of maximal safe surgical resection, followed by adjuvant chemoradiotherapy.
3 Several studies demonstrate that the extent of surgical resection is a determinant of progression-free and overall survival.
2 Achieving a gross total resection is surgically challenging, because the normal and tumor-bearing brain can be similar in intraoperative appearance.
3 A conservative resection by the surgeon can lead to suboptimal tumor debulking, whereas an aggressive technique may encroach on functionally significant brain. Various techniques have been employed to aid the neurosurgeon during tumor resection, including intraoperative MRI, neuronavigation, functional mapping via cortical stimulation, and ultrasonography.
3 None of these techniques allows the direct pathologic discrimination of tissue.
3